Energin R Technologies Ltd. (NRGene)

www.nrgene.com

High-Tech Company
Public Company

(TASE: NRGN)

TECH VERTICALS

AgriBiotech, AgriTech, Big Data, Bioinformatics, Biotechnology, Breeding, Crops, FoodTech, Genomics, Medical Cannabis, Plant-based, Software Applications

General Data

Sector	Agritech
Company Stage:	Revenue Growth
Established	2010
Number of Employees	55
Employees in Israel	40
Reg. Number:	abCDe

DESCRIPTION

NRGene is a genomic big data company that supports the global breeding industry boost the development of new plant and animal varieties by developing cutting edge predictive computational methods. NRGene's proprietary algorithms and software tools serve the rapidly expanding genomics market and replace the long and expensive processes of random field selection with big data based predictions.

TECHNOLOGY

DeNovoMAGIC 2.0TM routinely delivers the first-ever reference genomes for previously unmapped plants and animals. Moreover, DeNovoMAGIC 2.0TM is being used to better reveal intra-genetic variation in crops and organisms with already available reference genomes.

NRGene’s GenoMAGICTM provides a complete, accurate and cost-effective solution to completely handle and fully benefit from genomic’s big data. It delivers a dramatic increase in the efficacy of breeding efforts. GenoMAGICTM reconstructs and compares the full genome content of an unlimited number of individual plants and associates genome variability with field performance data. GenoMAGICTM been proven successful in analyzing most complex and diverse genomes, everything from maize and wheat to forestry and tomatoes.

GenoMAGIC™ analyzes complex genomic data and translates it into easy to manage information.

GenoMAGIC™, NRGene’s pan-genomic analysis platform, is a cloud-based solution for managing the full genomic diversity of a species of interest and is available for academic users as a full computational platform – GenoMAGICScholar™.

The potentially unlimited amount of material – based on publicly available genomic data – can be accessed on a dedicated graphical user interface, which enables easy visualization and query capabilities as well as information collaboration among team and community members.

ArrayMAGIC allows users to maximize the data found in their microarrays/GBS and obtain high resolution genomic information by imputing back from SNPs to full genomic sequences.
PanMAGIC produces an accurate genome-to-genome mapping and displays all types of sequence differences within the studied population including SNPs, InDels of any size, inversions, translocations, gene PAVs, and gene CNVs.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Seed & Breeding Companies and Academia.

	BUSINESS MODEL
	B2B

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
B2D01E2C-207A-E111-AC59-00155D32A403		Energin R Technologies Ltd. (NRGene)
855AF863-F38D-EE11-B812-00505695CD29	Spin-off	Supree Zanim Ltd.	Energin R Technologies Ltd. (NRGene)

CONTACT INFO

Expand / Collapse All

Main Address: Ness Ziona, Israel

Address	5 Golda Meir St., Park Hamada
City	Ness Ziona
Country	Israel
Zip	7403648

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: San Diego, United States

Address	8910 University Center Lane Suite 400
City	San Diego
State/Province	CA
Country	United States
Zip	92122

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Gil Ronen	CEO & Co-Founder
Dr. Kobi Baruch	CTO
Mr. Guy Kol	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Founder & CEO, Flow Group
abC Defghij	Board Member	President & CEO, Co-Founder, NRGENE
abC Defghij	Board Member	Co-Founder, Energin R Technologies Ltd. (NRGene)
abC Defghij	Board Member	Managing Partner, Roadmap RD Partners LP
abC Defghij	Board Member	CEO, Todos Technologies
abC Defghij	Board Member	Founder, BioDiligence

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Jan. 26, 2021	IPO	TASE	abCDe	abCDe	Raised NIS 100m, Valuation of NIS 370m.

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Third Round

Mar. 08, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Lending Fund	abCDe
abC Defghij	Investment Company	abCDe

Second Round

Jan. 01, 2017

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

First Round

Jun. 30, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Corporate VC	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Oct. 01, 2010

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Corporate VC	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jan. 01, 2025

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe